PRKCE and acute myeloid leukemia: Since PKCε has been reported to promote antioxidant capacity in AML (14) we assessed whether the PKCε overexpression lines showed resistance to other agents which induce oxidative stress (glucose oxidase, antimycin A, and arsenic trioxide).